Skip to main content
Article thumbnail
Location of Repository

Identification of Growth Hormone Receptor in Plexiform Neurofibromas of Patients with Neurofibromatosis Type 1

By Karin Soares Gonçalves Cunha, Eliane Porto Barboza and Eliene Carvalho da Fonseca
Topics: Clinical Sciences
Publisher: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
OAI identifier: oai:pubmedcentral.nih.gov:2664176
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. A et al. Increased expression of growth hormone and prolactin receptors in hepatocellular carcinomas.
    2. A genetic study of von Recklinghausen neurofibromatosis in South East Wales. II. Guidelines for genetic counselling.
    3. Association of acromegaly and chondrosarcoma.
    4. Benign and malignant tumors in patients with acromegaly.
    5. Da Fonseca EC. Identification of growth hormone receptor in localised neurofibromas of patients with neurofibromatosis type 1.
    6. Do hormonal contraceptives stimulate growth of neurofibromas? A survey on 59 NF1 patients.
    7. Elevated growth hormone levels in sera from breast cancer patients. Horm Metab Res.1985;17:421-4.
    8. (1988). Epidemiology and long-term survival in acromegaly: a study of 166 cases diagnosed between 1955 and 1984. Acta Med Scand.
    9. (1980). Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol.
    10. Expression of growth hormone receptor in benign and malignant cutaneous proliferative entities.
    11. (2004). genética e terapêutica. Rio de Janeiro:Guanabara Koogan;
    12. Growth hormone (GH), GH receptor, and signal transduction.
    13. Growth hormone and malignancy.
    14. Growth hormone in von Recklinghausen´s disease:reckless or recommended?
    15. (1998). Growth hormone receptor expression in the nucleus and cytoplasm of normal and neoplastic cells. Histochem Cell Biol.
    16. Leukemia and other malignancies among GH users.
    17. Leukemia in a patient treated with growth hormone.
    18. (1996). Molecular genetics of neurofibromatosis type 1 (NF1).
    19. (1998). Molecular mechanism of growth hormone signaling.
    20. (1999). Neurofibromatosis 1. Clinical Genetics. In:Friedman
    21. Neurofibromatosis 1. Neurofibromas and malignant tumors of the peripheral nerve sheath.
    22. Neurofibromatosis type 1 (NF1): a protein truncation assay yielding identification of mutations in 73% of patients.
    23. Neurofibromatosis type 1 and pregnancy.
    24. Neurofibromatosis update.
    25. (1999). Plexiform neurofibromas.
    26. Progesterone receptor expression in neurofibromas.Cancer Res.
    27. (1998). Selective desactivation of neurofibromin GAP activity in neurofibromatosis type 1 (NF1). Hum Mol Genet.
    28. (2000). SH2-B and SIRP:JAK2 binding proteins that modulate the actions of growth hormone. Recent Prog Horm Res,
    29. Specific estradiol binding in schawnnomas, meningiomas and neurofibromas.
    30. Steroid receptors in tumors of nerve sheath origin.
    31. Study Group. Evaluation of plasma hormone concentrations in relation to clinical staging in patients with prostate cancer.
    32. The effects of autocrine human growth hormone (hGH) on human mammary carcinoma cell behavior are mediated via the hGH receptor.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.